Literature DB >> 6038332

Chlorpromazine melanosis.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6038332      PMCID: PMC1842940     

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  14 in total

1.  The ocular toxic findings with prolonged and high dosage chlorpromazine intake.

Authors:  J R Siddall
Journal:  Arch Ophthalmol       Date:  1965-10

2.  Ocular melanosis with special reference to chlorpromazine.

Authors:  M E Cameron
Journal:  Br J Ophthalmol       Date:  1967-05       Impact factor: 4.638

3.  Uraemic accentuation of chlorpromazine pigmentation.

Authors:  K J Murphy
Journal:  Med J Aust       Date:  1966-12-24       Impact factor: 7.738

4.  An electron microscopic study of chlorpromazine pigmentation.

Authors:  K Hashimoto; W Wiener; J Albert; R G Nelson
Journal:  J Invest Dermatol       Date:  1966-10       Impact factor: 8.551

5.  Phenothiazines and eye complications.

Authors:  M Valentine; P Jardine
Journal:  Br Med J       Date:  1966-09-03

6.  [Phenothiazine retinopathy].

Authors:  H E Henkes
Journal:  Ned Tijdschr Geneeskd       Date:  1966-04-23

7.  Skin and eye changes associated with chlorpromazine therapy.

Authors:  G J Barnes; M E Cameron
Journal:  Med J Aust       Date:  1966-03-19       Impact factor: 7.738

8.  Pigmentation due to phenothiazines in high and prolonged dosage.

Authors:  A Satanove
Journal:  JAMA       Date:  1965-01-25       Impact factor: 56.272

9.  Skin pigmentation and chlorpromazine.

Authors:  A S Zelickson
Journal:  JAMA       Date:  1965-11-08       Impact factor: 56.272

10.  Ocular and cutaneous side effects after prolonged chlorpromazine treatment.

Authors:  G M Gombos; P E Yarden
Journal:  Am J Psychiatry       Date:  1967-01       Impact factor: 18.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.